Ozempic is a prescription medication designed for adults with type 2 diabetes. It contains semaglutide, a once-weekly injection that helps control blood sugar levels. While it’s gained widespread attention for weight loss, its FDA-approved purposes are specifically tied to diabetes and the serious complications that come with it.
The Three FDA-Approved Uses
Ozempic carries three distinct approvals, each targeting a different aspect of type 2 diabetes:
- Blood sugar control: Used alongside diet and exercise to lower blood sugar in adults with type 2 diabetes.
- Heart protection: Reducing the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes who already have heart disease.
- Kidney protection: Slowing the progression of chronic kidney disease in adults with type 2 diabetes, including reducing the risk of dialysis or kidney transplant. This approval came in January 2025 and marked a significant expansion of the drug’s role.
Ozempic is not approved for type 1 diabetes, and it hasn’t been studied in people with a history of pancreatitis.
How It Works in Your Body
Ozempic mimics a hormone your gut naturally produces called GLP-1. Your intestines release this hormone after you eat, but it breaks down within minutes. Semaglutide is engineered to last much longer, staying active for about a week.
Once injected, it does several things at once. It signals your pancreas to release more insulin, but only when your blood sugar is elevated, which lowers the risk of dangerous blood sugar drops. It also dials back glucagon, a hormone that tells your liver to dump sugar into the bloodstream. On top of that, it slows how quickly food leaves your stomach, which blunts the blood sugar spike that typically follows a meal. That slower digestion is also why many people feel full longer and eat less, which contributes to weight loss even though weight management isn’t one of Ozempic’s approved uses.
How Well It Controls Blood Sugar
In clinical trials, Ozempic produced substantial improvements in A1C, the measure of average blood sugar over roughly three months. At the 2 mg dose, patients saw an average A1C drop of 2.2 percentage points over 40 weeks. The 1 mg dose brought A1C down by 1.9 percentage points. To put that in perspective, many people with type 2 diabetes start with an A1C around 8% to 9%, and the general target is below 7%. A reduction of 2 points can be the difference between uncontrolled diabetes and hitting that goal.
Heart and Kidney Benefits
For people with type 2 diabetes and existing heart disease, Ozempic does more than manage blood sugar. In the SELECT trial, semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) by 20%. That’s a meaningful reduction for a population already at elevated risk.
The kidney approval, granted in early 2025, added another layer. For adults with type 2 diabetes and chronic kidney disease, Ozempic can slow the decline in kidney function and reduce the likelihood of progressing to end-stage kidney disease. The National Kidney Foundation called it an important milestone, since kidney disease is one of the most common and serious complications of diabetes, and treatment options have historically been limited.
Ozempic Is Not Wegovy
This is where confusion runs deepest. Ozempic and Wegovy contain the exact same active ingredient, semaglutide, made by the same company. But they’re approved for different purposes. Wegovy is the version specifically approved for weight management in adults and children 12 and older, as well as for reducing cardiovascular risk in adults with obesity or overweight and heart disease. It also has an approval for a type of liver disease called MASH.
The dosing differs too. Ozempic tops out at 2 mg per week, while Wegovy goes up to 2.4 mg. When doctors prescribe Ozempic “off-label” for weight loss, they’re using a diabetes drug at a lower maximum dose than the version built for that purpose. This off-label use has been so widespread that it has at times created shortages for the diabetes patients the drug was designed to help.
How Ozempic Is Taken
Ozempic is a once-weekly injection you give yourself using a pre-filled pen. The dose ramps up gradually to give your body time to adjust. You start at 0.25 mg weekly for the first four weeks, which isn’t really a treatment dose. It’s just getting your system accustomed to the drug. At week five, the dose increases to 0.5 mg. From there, your doctor may raise it to 1 mg or eventually to the 2 mg maximum, depending on how well your blood sugar responds and how you tolerate the medication. For people who also have chronic kidney disease, the increase to 1 mg may come after at least four weeks at the 0.5 mg level.
Common Side Effects
Stomach-related side effects are the most frequent complaint. In clinical trials, about 34% of patients on the 2 mg dose experienced gastrointestinal issues, compared to roughly 31% on the 1 mg dose. Nausea, vomiting, diarrhea, and stomach pain are the most commonly reported problems. These tend to be worst during the dose-increase phases and often improve over time as your body adjusts. The gradual titration schedule exists specifically to minimize these effects.
Who Should Not Take It
Ozempic is strictly off-limits for anyone with a personal or family history of medullary thyroid carcinoma, a rare type of thyroid cancer, or a condition called Multiple Endocrine Neoplasia syndrome type 2. In animal studies, semaglutide caused thyroid tumors, and while it’s not confirmed whether the same risk applies to humans, the contraindication stands as a precaution. Anyone who has had a serious allergic reaction to semaglutide or any ingredient in the injection should also avoid it.